Transcatheter Mitral Valve Replacement and Thrombosis: A Review

Mitral regurgitation is the most prevalent form of moderate or severe valve disease in developed countries. Surgery represents the standard of care for symptomatic patients with severe mitral regurgitation, but up to 50% of patients are denied surgery because of high surgical risk. In this context,...

Full description

Bibliographic Details
Main Authors: Guido Ascione, Paolo Denti
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.621258/full
_version_ 1819098625865678848
author Guido Ascione
Paolo Denti
author_facet Guido Ascione
Paolo Denti
author_sort Guido Ascione
collection DOAJ
description Mitral regurgitation is the most prevalent form of moderate or severe valve disease in developed countries. Surgery represents the standard of care for symptomatic patients with severe mitral regurgitation, but up to 50% of patients are denied surgery because of high surgical risk. In this context, different transcatheter options have been developed to address this unmet need. Transcatheter mitral valve replacement (TMVR) is an emergent field representing an alternative option in high complex contexts when transcatheter mitral valve repair is not feasible or suboptimal due to anatomical issues. However, TMVR is burdened by some device-specific issues (device malposition, migration or embolization, left ventricular outflow tract obstruction, hemolysis, thrombosis, stroke). Here we discuss the thrombotic risk of TMVR and current evidence about anticoagulation therapy after TMVR.
first_indexed 2024-12-22T00:33:58Z
format Article
id doaj.art-383eeebf8d8941a4af4efa95a4ab9795
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-12-22T00:33:58Z
publishDate 2021-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-383eeebf8d8941a4af4efa95a4ab97952022-12-21T18:44:51ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2021-06-01810.3389/fcvm.2021.621258621258Transcatheter Mitral Valve Replacement and Thrombosis: A ReviewGuido AscionePaolo DentiMitral regurgitation is the most prevalent form of moderate or severe valve disease in developed countries. Surgery represents the standard of care for symptomatic patients with severe mitral regurgitation, but up to 50% of patients are denied surgery because of high surgical risk. In this context, different transcatheter options have been developed to address this unmet need. Transcatheter mitral valve replacement (TMVR) is an emergent field representing an alternative option in high complex contexts when transcatheter mitral valve repair is not feasible or suboptimal due to anatomical issues. However, TMVR is burdened by some device-specific issues (device malposition, migration or embolization, left ventricular outflow tract obstruction, hemolysis, thrombosis, stroke). Here we discuss the thrombotic risk of TMVR and current evidence about anticoagulation therapy after TMVR.https://www.frontiersin.org/articles/10.3389/fcvm.2021.621258/fulltranscatheter mitral valve replacementthrombosisvitamin K antagonistsnon-vitamin K antagonist oral anticoagulantsmitral valve regurgitation
spellingShingle Guido Ascione
Paolo Denti
Transcatheter Mitral Valve Replacement and Thrombosis: A Review
Frontiers in Cardiovascular Medicine
transcatheter mitral valve replacement
thrombosis
vitamin K antagonists
non-vitamin K antagonist oral anticoagulants
mitral valve regurgitation
title Transcatheter Mitral Valve Replacement and Thrombosis: A Review
title_full Transcatheter Mitral Valve Replacement and Thrombosis: A Review
title_fullStr Transcatheter Mitral Valve Replacement and Thrombosis: A Review
title_full_unstemmed Transcatheter Mitral Valve Replacement and Thrombosis: A Review
title_short Transcatheter Mitral Valve Replacement and Thrombosis: A Review
title_sort transcatheter mitral valve replacement and thrombosis a review
topic transcatheter mitral valve replacement
thrombosis
vitamin K antagonists
non-vitamin K antagonist oral anticoagulants
mitral valve regurgitation
url https://www.frontiersin.org/articles/10.3389/fcvm.2021.621258/full
work_keys_str_mv AT guidoascione transcathetermitralvalvereplacementandthrombosisareview
AT paolodenti transcathetermitralvalvereplacementandthrombosisareview